Trim 15-20% into upper Bollinger resistance at $161-162; maintain core long position with $156 stop
Underweight rating on XOM is an execution framework for trimming into upper Bollinger resistance ($161-162), not a directional cycle-peak call. The 15-20% trim captures position compression for parking-drift drag and technical extension risk while preserving core long exposure for the 2.6% dividend yield and structural floor (rising 200 SMA, 0.17 beta, 1.37x FCF coverage). Hard stop at $156 (1.5 ATR) vs. the overreaching $147 stop (4.0 ATR). Q3 2026 earnings in late October is the binding reassessment gate: FCF >$12B with intact EPS = re-engage toward neutral; FCF <$10B or EPS cut to $9.00-9.50 = full Sell. The structural floor has held through two consecutive Underweight calls, warranting this more calibrated trim framework over directional conviction.
| Position | Action |
|---|---|
| Default position | Preserve 80-85% as core long for dividend capture and structural floor exposure |
| At resistance ($161-162 zone) | Trim 15-20% of XOM exposure laddered across upper Bollinger band |
| Parking-drift pattern with high variance | Compress position size toward lower bound |
XOM is a BUY at $161.46 with $185-190 target, driven by Q2 2026 earnings inflection, structural geopolitical oil premium, 15.17x forward P/E discount, and 0.47x Net Debt/EBITDA with $37.5B annual capital return.
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | $147.76 | bullish |
| 200 SMA | $140.56 | bullish |
| 10 EMA | $158.14 | bullish |
| RSI | 66.27 | bullish |
| MACD Line | +3.46 | bullish |
| MACD Signal | +3.19 | bullish |
| MACD Histogram | +0.28 | bullish |
| Bollinger Upper Band | $162.12 | neutral |
| Bollinger Middle Band | $156.25 | neutral |
| Bollinger Lower Band | $150.38 | neutral |
| ATR (14) | $3.63 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Breakout above $162.12 on volume >15M
Then: Rebuild to neutral/Hold ahead of Q3 earnings
Q2 2026 represents an earnings inflection quarter, not a cyclical fluke
↩ rebuts: “Bear anchoring on 2023-2025 trough data and calling Q2 a cyclical one-off”
EV: +18% (to $190 at 18x forward P/E); target $185-190; Risk/Reward ~2.5:1 · concedes: Cyclical exposure exists; XOM is leveraged to oil prices which could decline $15-20/bbl; Capex increasing 54% creates near-term FCF compression; Working-interest share on some projects is declining; Windfall tax risk, while legislatively unlikely, cannot be fully dismissed
XOM at $161.46 is overbought, overlevered relative to normalized cash flows, and entirely dependent on sustained geopolitical disruption for its premium valuation—making it a high-risk SELL at 95% of its 52-week high with asymmetric downside.
EV: -$25 to -$30 (downside if geopolitical premium normalizes) · concedes: 17.5% rally in 45 days is real and happened; Q2 2026 $14.5B net income is a genuine earnings beat; Dividend is safe and covered by operating cash flow; Net debt/EBITDA at 0.47x is manageable at current oil prices; Working interest decline does produce higher absolute dollar returns at $89 Brent
→ vs conservative: Peak-cycle argument is 'flat wrong' — 2023-2025 was the trough of a multi-year down-cycle, not the prelude to one; Q2 2026 is the second leg of a marathon, not the finish line
→ vs conservative: Capital return concern ($37.5B returns vs $20.7B TTM FCF) uses wrong denominator capturing the trough; forward FCF will explode as Q2 $28.3B EBITDA annualizes to ~$113B
→ vs neutral: 'Trim some, hold core' underestimates magnitude of position needed; Iran situation is central case (not tail risk) with 1% resolution odds, requiring full overweight positioning
→ vs conservative: '9% from 52-week high' framing misleads — stock round-tripped 22% to $137.46 and is rebuilding support, not peaking; $176.41 set under different conditions
→ vs neutral: Any trim should be anchored to patience for multi-month geopolitical premium to unwind, not fear of peak cycle; this is cleanest cash-flow story in S&P 500
| neutral |
Support: 140.56 · 147.76 · 150.38 · 156.25 · 158.14 | Resistance: 162.12
Technical analysis shows a textbook bullish trend with breakout test underway. Price ($161.46) is trading above all key moving averages with both 50 SMA ($147.76) and 200 SMA ($140.56) rising, confirming sustained structural support. MACD flipped positive on July 17 and histogram is expanding (+0.28), indicating accelerating upside momentum. RSI at 66.27 is below the 70 overbought threshold, leaving room for further upside. Price is pressing the upper Bollinger band at $162.12; a clean break above would confirm continuation, while rejection could trigger a pullback to the $156-$158 zone. ATR compression from $4.45 to $3.63 suggests an orderly trend with manageable volatility. Final transaction proposal: HOLD existing longs; consider adding on pullbacks to $158 (10 EMA) or $156 (Bollinger middle) rather than chasing into upper-band resistance.
Market Cap
$663.9B
Share Price (50-day avg)
$147.57
200-day Average
$141.32
52-Week High
$176.41
52-Week Low
$105.67
Beta
0.173
P/E (TTM)
20.81x
Forward P/E
15.17x
PEG Ratio
1.25
Price-to-Book
2.56x
Dividend Yield
2.57%
Revenue (TTM)
$361.1B
Gross Profit (TTM)
$107.5B
EBITDA (TTM)
$67.9B
Net Income (TTM)
$32.8B
Diluted EPS (TTM)
$7.76
Forward EPS
$10.64
Operating Margin (TTM)
15.86%
Profit Margin
9.07%
Return on Equity (ROE)
12.58%
Return on Assets (ROA)
5.52%
Current Ratio
1.14x
Cash (Q2 2026)
$10.6B
Total Debt
$42.4B
Net Debt
$31.8B
Net Debt/EBITDA
0.47x
Total Assets
$464.5B
Stockholders' Equity
$259.4B
Operating Cash Flow (2025)
$52.0B
Capex (2025)
$28.4B
Free Cash Flow (TTM)
$20.7B
Dividends Paid (2025)
$17.2B
Buybacks (2025)
$20.3B
Combined Shareholder Returns (2025)
$37.5B
Strengths
Concerns
ExxonMobil is a high-quality integrated energy supermajor with a fortress balance sheet (Net Debt/EBITDA of 0.47x) that is emerging from a multi-year commodity down-cycle. Q2 2026 marked a clear inflection point with blowout earnings, validating the cyclical recovery thesis, while forward valuation (15.2x P/E) remains reasonable relative to the 37% expected EPS growth. Capital allocation remains best-in-class with $37.5B returned to shareholders in 2025, though rising capex and net debt warrant monitoring as the company funds its Permian expansion and low-carbon investments.
Macro: US-Iran hostilities resumed after ceasefire expired; Strait of Hormuz nearly shut down; Brent crude at ~$89/bbl; Fed on hold with 85% probability of zero rate cuts in 2026; US recession only 8% (low); Japan recession 56% (rising sharply); Polymarket volume on Iran invasion at $58.8M indicates high-conviction market pricing of tail risk.